Diagnostics for AMR: Building Back Better from the COVID-19 Pandemic

What lessons can the antimicrobial (AMR) response take from COVID-19 events?

As the world continues to deal with COVID-19, its impact on other public health issues must also be considered. This three-week course provides valuable insight into how COVID-19 affected different countries’ One Health efforts in general, and their antimicrobial resistance responses in particular.

Unpack COVID-19’s impact on AMR diagnostics

The course starts with a close examination of the impact that the COVID-19 pandemic has had on One Health projects and delivery in different countries, and on AMR stewardship and responses.

With a clear understanding of the effects, you’ll be able to explore the lessons and benefits that the responses to the COVID-19 pandemic (and the pandemic itself) hold for AMR research and action plans.

See what AMR and One Health can take from COVID-19 events

The importance of quality and informatics for AMR diagnostics, AMR data sharing, and overall collaboration within the public health sector will all be emphasised on the course.

You’ll also learn more about the diagnostic technology innovations and diagnostic capacity increases that developed in response to COVID-19, and how they can be applied to the AMR response.

Ultimately, you’ll gain new appreciation for the need for continuous learning, professional development, and information sharing in the fight against AMR by the end of the course.

Learn at the cutting edge of AMR research with LSHTM

The London School of Hygiene & Tropical Medicine (LSHTM) is ideally suited to present this course on AMR diagnostics, surveillance, reporting, and responding.

Besides having a proven record for launching excellent online courses with Becton Dickinson and Company (their partner in this course), the LSHTM is a recognised leader in global and public health.

This insightful course from the LSHTM is designed for anyone interested in the public health aspects of AMR control, including policy and decision-makers and healthcare professionals, students, and educators.

• Updates on the AMR response and the impact of the COVID-19 pandemic
• Introduction
• Review of AMR progress since 2013
• Impact of the COVID-19 pandemic on AMR programmes
• Novel diagnostic technologies developed for the COVID-19 pandemic
• Summary of Week 1
• Better diagnosis, surveillance and reporting for AMR
• Introduction to Week 2
• Clinical Case Study
• Update on Management of Common Clinical Syndromes
• AMR Technology Update
• Summary of Week 2
• Building back better for a robust and sustainable AMR response
• Introduction to Week 3
• Lessons learnt from the COVID-19 pandemic to leverage for AMR
• Building quality laboratory systems for AMR
• Building data systems and data as a Public Good
• Partnerships for AMR
• Summary